IL37 and atherosclerosis: Evidence for the protective effect of IL-37 on diverse inflammatory conditions through attenuating cellular apoptosis of disease-related target cells or tissues has been accumulating in inflammatory conditions such as acute respiratory distress syndrome (ARDS), diabetic nephropathy, and atherosclerosis [40,41,42].